Опубликовать статью

Информационное партнерство

Инфоресурсы

Контакты

«

Vol. 14, Art. 3 (pp. 28-39)    |    2013       

»

Evolution of structure of induced second tumors after primary childhood Ewing’s sarcoma

Kulyova S.A.

N.N. Petrov Research Institute of Oncology

Brief summary

An effort was made to accentuate correlations between structure of methachronic tumors and kinds of treatment for Ewing’s sarcoma family tumors with using combined results of randomized researches. Epidemiological features of developing malignant tumor under the action of ionizing radiation and the carcinogenic action of some cytostatics, are discussed extensively.


Key words

children, Ewing’s sarcoma, induced second tumor

Reference list

1. Savva N.N., Zborovskaya A.A., Aleinikova O.V. Zlokachestvennie novoobrazovaniya y detei respybliki Belarys: Zabolevaemost, vijivaemost, smertnost i palliativnaya pomosh. – Minsk: GY RNMB, 2008. – 184 s.


2. Bacci G., Longhi A., Barbieri E. et al. Second malignancy in 597 patients with Ewing sarcoma of bone treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999 // J. Ped. Hematol. Oncol. – 2005. – V. 27. – P. 517-520.


3. Bacci G., Toni A., Avella M. et al. Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy // Cancer. – 1989. – V.63. – P. 1477-1486.


4. Bhatia S., Krailo M.D., Chen Z. et al. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: a report from the Children’s Oncology Group // Blood. – 2007. – V. 109. – P. 46-51.


5. Burdach S., Van Kaick B., Laws H.J. et al. Allogenic and autologous stem-cell transplantation in advanced Ewing tumors: an update after long-term follow-up from two centers of the European intergroup study EICESS. Stem-Cell Transplant Programs at Dusseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria // Ann. Oncol. – 2000. – V. 11. - P. 1451-1462.


6. Dunst J., Ahrens S., Paulussen M. et al. Second malignancies after treatment for Ewing’s sarcoma: a report of the CESS-studies // Int. J. Rad. Oncol. Biol. Phys. – 1998. – V. 42. – P. 379-384.


7. Fuchs B., Valenzuela R.G., Inwards C. et al. Complications in long-term survivors of Ewing sarcoma // Cancer. – 2003. – V. 98. – P. 2687-2692.


8. Ginsberg J.P., Goodman P., Leisenring W. et al. Long-term survivors of childhood Ewing sarcoma: report from the Childhood Cancer Survivor Study // J. Nat. Cancer Inst. – 2010. – V. 102. – P. 1272-1283.


9. Kuttesch Jr. J.F., Wexler L.H., Marcus R.B. et al. Second malignancies after Ewing’s sarcoma: radiation dose-dependency of secondary sarcoma // J. Clin. Oncol. – 1996. - V. 14. – P. 2818-2825.


10.McLean T.W., Hertel C., Young M.L. et al. Late events in pediatric patients with Ewing sarcoma/primitive neuroectodermal tumor of bone: the Dana-Faber Cancer Institute/Children’s Hospital experience // J. Ped. Hemat. Oncol. – 1999. – V. 21. – P. 486-493.


11. Navid F., Billups C., Liu T. et al. Second cancer in patients with the Ewing sarcoma family of tumours // Eur. J. Cancer. – 2008. – V. 44. – P. 983-991.


12. Paulino A.C., Nguyen T.X., and Mai W.Y. An analysis of primary site control and late effects according to local control modality in non-metastatic Ewing sarcoma // Ped. Blood Cancer. – 2007. – V. 48. – P. 423-429.


13. Paulussen M., Ahrens S., Lehnert M. et al. Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study // Ann. Oncol. – 2001. – V. 12. – P. 1619-1630.


14. Pui C.-H., Ribeiro R., Hancock M.L. et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphocytic leukemia // N. Engl. J. Med. – 1991. – V. 325. – P. 1682-1587.


15. Smith M.A., McCaffrey R.P., Karp J.E. The secondary leukemias: challenges and research directions // J. Natl. Cancer Inst. – 1996. – V. 88. – P. 407-418.


16. Smith M.A., Rubinstein L., Anderson J.R. et al. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophylloxins // J. Clin. Oncol. – 1999. – V. 17. – P. 569-577.


17. Strong L.C., Herson J., Osborne B.M., and Sutow W.W. Risk of radiation related subsequent malignant tumors in survivors of Ewing’s sarcoma // J. Nat. Cancer. Inst. – 1979. – V. 62. – P. 1401-1406.


18. Sultan I., Rihani R., Hazin R., and Rodriguez-Galindo C. Second malignancies in patients with Ewing sarcoma family of tumors: a population-based study // Acta Oncologica. – 2010. - V. 49. – P. 237-244.


19. Tucker M.A., D’Angio G.J., Boice Jr. J.D. et al. Bone sarcomas linked to radiotherapy and chemotherapy in children // N. Engl. J. Med. – 1987. – V. 317. – P. 588-593.